Publications by authors named "Nathan Robison"

Claim this Profile
A
A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4.
Jason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, Shelly Lensing, Azra H Ligon, Nathan J Robison

Neuro Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of classical astroblastoma features in pediatric MN1::BEND2-fused brain tumors.
Nicholas Chapman, Mohammed Iqbal, Adam D Walker, Debra Hawes, Tom Belle Davidson, Nathan Robison

Brain Pathol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.
Christopher L Moertel, Angela C Hirbe, Hans H Shuhaiber, Kevin Bielamowicz, Alpa Sidhu, Nathan J Robison

J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions.
Audrey-Anne Lamoureux, Michael J Fisher, Lauriane Lemelle, Elke Pfaff, Pouneh Amir-Yazdani, Nathan J Robison

Clin Cancer Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma Coalition.
Patricia O'Hare, Tabitha Cooney, Peter de Blank, David H Gutmann, Mark Kieran, Nathan J Robison

Neuro Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective re-induction regimen for children with recurrent medulloblastoma.
Katrina O'Halloran, Sheetal Phadnis, Gregory K Friedman, Katie Metrock, Tom B Davidson, Nathan J Robison

Neurooncol Adv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group.
Sabine Mueller, Jason Fangusaro, Arzu Onar Thomas, Thomas S Jacques, Pratiti Bandopadhayay, Nathan J Robison

Neuro Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Exome Capture-Based RNA-Sequencing Assay for Genome-Wide Identification and Prioritization of Clinically Important Fusions in Pediatric Tumors.
Jonathan Buckley, Ryan J Schmidt, Dejerianne Ostrow, Dennis Maglinte, Moiz Bootwalla, Nathan Robison

J Mol Diagn· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047).
Michelle Monje, Tabitha Cooney, John Glod, Jie Huang, Cody J Peer, Nathan J Robison

Neuro Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addendum: Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy.
Stephanie A Toll, Hung N Tran, Jennifer Cotter, Alexander R Judkins, Benita Tamrazi, Nathan J Robison

Oncotarget· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.
Peter M K de Blank, Andrea M Gross, Srivandana Akshintala, Jaishri O Blakeley, Gideon Bollag, Nathan Robison

Neuro Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac Function in Children and Young Adults Treated with MEK Inhibitors: A Retrospective Cohort Study.
Nathan J Robison, Jennifer A Su, Melody J Fang, Jemily Malvar, Jondavid Menteer

Pediatr Cardiol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric Gliosarcoma With and Without Neurofibromatosis Type 1: A Whole-exome Comparison of 2 Patients.
Richard T Graham, Erica H Bell, Amy Webb, Yue Zhao, Cynthia Timmers, Nathan J Robison

J Pediatr Hematol Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children.
Nicole J Ullrich, Sanjay P Prabhu, Roger J Packer, Stewart Goldman, Nathan J Robison

Pediatr Blood Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.
Brian D Weiss, Pamela L Wolters, Scott R Plotkin, Brigitte C Widemann, James H Tonsgard, Nathan J Robison

J Clin Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of comprehensive genomic profiling in central nervous system tumors of children and young adults.
Jianling Ji, Kristiyana Kaneva, Matthew C Hiemenz, Girish Dhall, Tom Belle Davidson, Nathan J Robison

Neurooncol Adv· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report.
Stewart Goldman, Ian F Pollack, Regina I Jakacki, Catherine A Billups, Tina Y Poussaint, Nathan J Robison

Neuro Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study.
Nicole J Ullrich, Sanjay P Prabhu, Alyssa T Reddy, Michael J Fisher, Roger Packer, Nathan J Robison

Neuro Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Jason Fangusaro, Olaf Witt, Pablo Hernáiz Driever, Asim K Bag, Peter de Blank, Nathan J Robison

Lancet Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and neuropsychological outcome of pediatric non-midline central nervous system germinoma treated with chemotherapy and reduced dose/volume irradiation: The Children's Hospital Los Angeles experience.
Kee Kiat Yeo, Kimberly Kayser, Ashley S Margol, Kenneth K Wong, Nathan Robison

Pediatr Blood Cancer· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of molecular subgroups of medulloblastoma in young children receiving irradiation-sparing regimens.
Kee Kiat Yeo, Ashley S Margol, Rebekah J Kennedy, Long Hung, Nathan J Robison

J Neurooncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusual radiological and histological presentation of a diffuse leptomeningeal glioneuronal tumor (DLGNT) in a 13-year-old girl.
Nishant Tiwari, Benita Tamrazi, Nathan Robison, Mark Krieger, Jianling Ji

Childs Nerv Syst· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained response of three pediatric BRAF mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy.
Stephanie A Toll, Hung N Tran, Jennifer Cotter, Alexander R Judkins, Benita Tamrazi, Nathan J Robison

Oncotarget· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative analysis of clinicopathological features and survival among early adolescents/young adults and children with low-grade glioma: a report from the Children's Oncology Group.
Ashley S Margol, Kee Kiat Yeo, Caihong Xia, Arzu Onar, Nathan J Robison

J Neurooncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma.
Nalin Gupta, Liliana C Goumnerova, Peter Manley, Susan N Chi, Donna Neuberg, Nathan J Robison

Neuro Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis